Siamak Baharloo

Siamak Baharloo is a Boston-based entrepreneur who is a Doctor of Philosophy (Human/Medical Genetics) and CEO of Labviva, a SaaS company in the healthcare purchasing space.[1] Baharloo founded the company in 2017 and raised significant funds from MassVentures, Village Global, Glasswing Ventures,[2] and Tech Coast Angels.[3] He is best known for his advocacy for platform tools for complex business such as biopharmaceutical research.[4]

Siamak Baharloo
Alma materUniversity of Maryland, Baltimore County, University of California, San Francisco
EmployerLabviva
TitleCo-Founder and CEO

Education and research

Baharloo earned a B.A.S.c (B.A.Sc.) in Biochemistry and Molecular Biology from the University of Maryland, Baltimore County and a Ph.D. in genetics from the University of California, San Francisco. While at UCSF, he performed extensive genetic research and published papers on many of his findings, including work regarding Byler syndrome,[5] intrahepatic cholestasis,[6] and bipolar disorder[7] His work remains well-cited.[8] His graduate dissertation explored the genetic basis for perfect pitch and was based on a study of 500 musicians. Baharloo's work found evidence that the some of the ability to instantly recognize musical notes is inherited.[9]

Baharloo is the holder or co-holder of several patents related to the intersection of scientific protocols and commerce.[10]

Business career

After working on a genetic mapping project that extensively leveraged technology, rather than staying in academia, Baharloo pursued a business career specializing in e-business and e-commerce for the healthcare industry.[11] He worked for large healthcare organizations like Merck Group[12] and Thermo Fisher Scientific[13] in an executive capacity before going on to found his own company.[14]

References
  1. "Organization: Labviva". Crunchbase. Crunchbase Inc. Retrieved 12 November 2020.
  2. "Glasswing Ventures Invests in Five Pre-Seed Frontier Tech Startups". Medium. Glasswing Ventures. Retrieved 12 November 2020.
  3. Fidler, Kimber. "Tech Coast Angels Invest More Than $9.7 Million in 31 Companies in 1H 2020". PR Web. Tech Coast Angels. Retrieved 12 November 2020.
  4. "Old Businesses Must Learn New Platform Tricks to Survive". Medium. MIT Initiative on the Digital Economy. Retrieved 17 November 2020.
  5. Bull, Laura Nanine (1997). "Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity". Hepatology (Baltimore, Md.). Hepatology. 26 (1): 155–64. doi:10.1002/hep.510260121. PMID 9214465. S2CID 35040329. Retrieved 12 November 2020.
  6. Houwen, Roderick H. J. (1994). "Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis". Nature Genetics. 8 (4): 380–6. doi:10.1038/ng1294-380. PMID 7894490. S2CID 8131209. Retrieved 12 November 2020.
  7. McInnis, L. Alison. "A complete genome screen for genes predisposing to severe bipolar disorder in 2 Costa Rican pedigrees". Research Gate. Proceedings of the National Academy of Sciences. Retrieved 12 November 2020.
  8. Semantic Scholar. Allen Institute for AI https://www.semanticscholar.org/author/S.-Baharloo/4657326. Retrieved 12 November 2020. Missing or empty |title= (help)
  9. Daly, Michael. "Science : Keeping perfect pitch in the family". New Scientist. New Scientist LTD. Retrieved 19 November 2020.
  10. "Patents by Inventor Siamak Baharloo". Justia. Justia. Retrieved 19 November 2020.
  11. "SIAMAK BAHARLOO PH.D." Early.com. EARLEY INFORMATION SCIENCE, INC. Retrieved 12 November 2020.
  12. Hoff, Gregg. "New Data Visualization Application Aims to Accelerate Lead Discovery". PR Web. Cision. Retrieved 12 November 2020.
  13. "Platform Economy Summit". Informa. Infrorma Connect. Retrieved 12 November 2020.
  14. Thomas, Lynda. "New Digital Marketplace for Life Science Products – Built with Scientists in Mind". Business Wire. Berkshire Hathaway. Retrieved 12 November 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.